Lipocine Inc <LPCN.OQ> expected to post a loss of 40 cents a share - Earnings Preview
Lipocine Inc LPCN.OQ LPCN.O is expected to show a rise in quarterly revenue when it reports results on August 6 (estimated) for the period ending June 30 2025
The Salt Lake City Utah-based company is expected to report a 155.7% increase in revenue to $229 thousand from $89.57 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for Lipocine Inc is for a loss of 40 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Lipocine Inc is $7.38, about 57.3% above its last closing price of $3.15
This summary was machine generated August 4 at 14:18 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
